pa9159

PA9159 is a structurally novel and highly potent intranasal glucocorticoid (corticosteroid) developed for the treatment of allergic rhinitis, including both seasonal and perennial forms. It is administered as a nasal spray. Clinical studies have shown that PA9159 is safe and well-tolerated at tested doses, with mainly mild and transient local nasal adverse events reported. The drug does not appear to significantly affect morning serum cortisol levels, suggesting minimal systemic corticosteroid effects. The mechanism of action has not been fully defined but is consistent with other corticosteroids used in allergic rhinitis—likely involving anti-inflammatory activity via glucocorticoid receptor agonism[1][2][3][5][7].